| 000 | 01758 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514020207.0 | ||
| 264 | 0 | _c20020117 | |
| 008 | 200201s 0 0 eng d | ||
| 022 | _a0002-9394 | ||
| 024 | 7 |
_a10.1016/s0002-9394(01)01267-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChandra, N S | |
| 245 | 0 | 0 |
_aCluster of Mycobacterium chelonae keratitis cases following laser in-situ keratomileusis. _h[electronic resource] |
| 260 |
_bAmerican journal of ophthalmology _cDec 2001 |
||
| 300 |
_a819-30 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnti-Bacterial Agents |
| 650 | 0 | 4 |
_aBacterial Proteins _xanalysis |
| 650 | 0 | 4 | _aCalifornia |
| 650 | 0 | 4 | _aCluster Analysis |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aCornea _xmicrobiology |
| 650 | 0 | 4 |
_aDrug Therapy, Combination _xtherapeutic use |
| 650 | 0 | 4 | _aElectrophoresis, Gel, Pulsed-Field |
| 650 | 0 | 4 |
_aEye Infections, Bacterial _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperopia _xsurgery |
| 650 | 0 | 4 |
_aKeratitis _xdrug therapy |
| 650 | 0 | 4 |
_aKeratomileusis, Laser In Situ _xadverse effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMycobacterium Infections, Nontuberculous _xdrug therapy |
| 650 | 0 | 4 |
_aMycobacterium chelonae _xisolation & purification |
| 700 | 1 | _aTorres, M F | |
| 700 | 1 | _aWinthrop, K L | |
| 700 | 1 | _aBruckner, D A | |
| 700 | 1 | _aHeidemann, D G | |
| 700 | 1 | _aCalvet, H M | |
| 700 | 1 | _aYakrus, M | |
| 700 | 1 | _aMondino, B J | |
| 700 | 1 | _aHolland, G N | |
| 773 | 0 |
_tAmerican journal of ophthalmology _gvol. 132 _gno. 6 _gp. 819-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0002-9394(01)01267-3 _zAvailable from publisher's website |
| 999 |
_c11644477 _d11644477 |
||